A new male medical product could save billions of lives in the next 20 years, the head of the U.S. National Institutes of Health has predicted.
“It’s the first time we’ve seen a male pill,” Dr. Paul Offit, chief of the Division of Cardiology at Massachusetts General Hospital, said Tuesday at the World Health Organization conference in Geneva.
“If you’re looking at the cost, it’s almost impossible.
It’s very difficult to come up with the right cost to be able to produce this pill.”
Offit said he is convinced that the male pill will work and will save lives, but he was cautious because he has not seen a single clinical trial.
He said a study on male contraceptive efficacy will take several years.
The male pill, called lopinavir, has been available in some form for decades in Europe, Australia, and Canada.
In the U, it is sold under a brand name, and in New York state it is also sold under the brand name Norplant.
But it is the only male-specific contraceptive pill available in the U that works on the male contraceptive receptor, or MCR, which is found in sperm and makes it easier to become pregnant.
The male pill was approved by the Food and Drug Administration in 2000.
In the first trial of a male contraceptive pill, the U of Minnesota and the University of Utah completed about 3,000 men.
It was part of a larger effort to study the efficacy of the male contraceptives, called levonorgestrel, on the fertility of both men and women.
In recent years, research has shown that male contraceptive pills may be more effective than female contraceptives in lowering the risk of developing certain cancers.
The new male pill would have a longer half-life and a lower dose than previous versions of the pill, but it would be less effective than the current male contraceptive drugs.
The pills have a much lower half-lives, and the longer half lives allow the pills to be taken longer than the other male contraceptives.
But it is important to note that the pill is not as effective as male contraceptives for preventing the pregnancy.
The U.K.’s Department of Health published an analysis in 2015 showing that the current female contraceptive pill is as effective in preventing pregnancy as the male birth control pill.
The U.N. Committee on Economic, Social and Cultural Rights also reported in 2016 that the pills are as effective at preventing pregnancy and sexually transmitted diseases as the pill used by the U